The effect of recombinant factor VIIa (NovoSeven®) on peri-operative bleeding during total knee replacement in a non-hemophiliac patient

Journal Title: Ortopedia Traumatologia Rehabilitacja - Year 2004, Vol 6, Issue 4

Abstract

Background. Recombinant factor VIIa has been in use for some time to control bleeding in persons with hemophilia. In the present study we describe our experience with the use of a commercial form of recombinant factor VIIa, NovoSeven® (Novo Nordisk, Denmark), to control perioperative bleeding in the course of total knee replacement on a patient who, though not hemophiliac, had a very low tolerance for blood loss. Case report. A 44-year-old patient with anemia and rheumatoid arthritis, with a history of significant perioperative blood loss was referred for total knee replacement. The employment of two relatively small doses of NovoSeven® caused a considerable decrease in peri-operative surgical site bleeding, and post-operative blood loss from the surgical wound within the first 20 hours after the procedure was easily controlled. No complications were encountered.Conclusions. NovoSeven® can be used safely and successively to control perioperative bleeding even in non-hemophiliac patients.

Authors and Affiliations

Bogusław Frańczuk, Edyta Derlatka, Yosef Freedland

Keywords

Related Articles

Errors in Treatment of Fractures of Distal Femur by LISS Method (Less Invasive Stabilization System) – Single-centre Experience

Background. LISS, the newest surgical method, makes it possible to completely regain knee function after knee fractures. We share our experience of the most frequently occurring errors during LISS-based treatment and way...

Analiza długości przeżycia i pobytu w szpitalu chorych ze złamaniem okołokrętarzowym kości udowej (AO 31A1-A3)

Wstęp: Leczenie operacyjne chorych ze złamaniem okołokrętarzowym kości udowej jest metodą z wyboru. Celem pracy była analiza długości przeżycia i pobytu w szpitalu chorych w zależności od wyboru metody operacyjnej or...

Bone Diaphysis Metastases, the Ways and Results of Surgical Treatment Saving the Joints

Background. A consequence of the progress in oncological treatment is an increasing number of bone complications asso­ciated with metastases. With appropriate choice of oncological treatment and appropriate surgical mana...

Ocena chodu pacjenta leczonego obustronną aloplastyką stawów biodrowych. Studium przypadku

Endoprotezoplastyka (THA) jest jedną z najskuteczniejszych metod leczenia zaawansowanej artrozy biodra (HOA). W wielu przypadkach, pomimo prawidłowo przeprowadzonego zabiegu operacyjnego, wciąż pozostają utrwalone patolo...

Botulinum toxin type A in the treatment of spasticity in cerebral palsy: theoretical and practical foundations of effective therapy

Spasticity is one of the constituent elements of upper motor neuron syndrome. For now, it is also the only symptom which is pharmacologically treatable. The pathophysiology of spasticity is very complex, and many aspects...

Download PDF file
  • EP ID EP56213
  • DOI -
  • Views 148
  • Downloads 0

How To Cite

Bogusław Frańczuk, Edyta Derlatka, Yosef Freedland (2004). The effect of recombinant factor VIIa (NovoSeven®) on peri-operative bleeding during total knee replacement in a non-hemophiliac patient. Ortopedia Traumatologia Rehabilitacja, 6(4), 483-489. https://europub.co.uk./articles/-A-56213